Acetaminophen Child Strawberry Oral Suspension Recalled for Contaminated Excipient
Perrigo Company PLC is recalling Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml) nationwide due to manufacturing with a contaminated excipient that was itself recalled by the supplier.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a CGMP deviation with use of a contaminated excipient. No illnesses or injuries are reported in the source text, and the nature of the contamination is not specified. The recall is precautionary rather than responsive to documented harm.
Plain-English summary
Perrigo Company PLC is recalling Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) bottles with NDC 37808-759-26, distributed nationwide in the USA.
The recall was initiated because the product was manufactured using a contaminated excipient that had been recalled by the supplier. This represents a deviation from current Good Manufacturing Practice (CGMP) standards.
The affected batch is 1GK0905 with an expiration date of 01/31/2023. Consumers who have this product should discontinue use and consult with their healthcare provider or pharmacist regarding appropriate alternatives.
The recalled product
- Product
- Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) per bottle, MADE WITH PRIDE & CARE FOR H-E-B SAN ANTONIO, TX 78204. NDC: 37808-759-26
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Oral Suspension
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1GK0905
- Exp 01/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27